AKT1 and cancer: Notably, CK2 is overexpressed in cancer cells of the prostate, colon, lung and breast, and takes a critical part in cancer progression by regulating a number of signaling pathways, including PI3K/Akt, Wnt/β-catenin and MAPK [12–14].